Anthony D'Adamio - Mar 14, 2022 Form 4 Insider Report for Bioventus Inc. (BVS)

Role: SVP & General Counsel
Signature: /s/Anthony D'Adamio
Stock symbol: BVS
Transactions as of: Mar 14, 2022
Transactions value $: $0
Form type: 4
Date filed: 4/12/2023, 09:03 PM
Previous filing: Feb 15, 2022
Next filing: Apr 5, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	BVS	Class A Common Stock						45.6K	Mar 14, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BVS	Stock Option (Right to Buy)	Award	$0	+96.1K		$0.00	96.1K	Mar 14, 2022	Class A Common Stock	96.1K	$12.66	Direct	F1
transaction	BVS	Restricted Stock Units	Award	$0	+39.7K		$0.00	39.7K	Apr 10, 2023	Class A Common Stock	39.7K		Direct	F2, F3
transaction	BVS	Stock Option (Right to Buy)	Award	$0	+104K		$0.00	104K	Apr 10, 2023	Class A Common Stock	104K	$1.16	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options shall vest in four equal installments on each of the first four anniversaries of March 14, 2022, in each case subject to the Reporting Person continuing in service through the applicable vesting date.
F2	Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F3	The RSUs and options, as applicable, shall vest in four equal installments on each of the first four anniversaries of April 10, 2023, in each case subject to the Reporting Person continuing in service through the applicable vesting date.